151. Secondary Metabolites from an Actinomycete from Vietnam's East Sea
- Author
-
Van Cuong Pham, Van Minh Chau, Quyen Vu Thi, Huong Doan Thi Mai, Brian T. Murphy, Cong V inh Le, Min L e Thi Hong, and Van Hieu Tran
- Subjects
Antifungal Agents ,Stereochemistry ,Oceans and Seas ,Antineoplastic Agents ,Plant Science ,medicine.disease_cause ,01 natural sciences ,Actinobacteria ,chemistry.chemical_compound ,Drug Discovery ,medicine ,Seawater ,Benzamide ,Candida albicans ,Escherichia coli ,Pharmacology ,Molecular Structure ,biology ,010405 organic chemistry ,Ecology ,General Medicine ,Antimicrobial ,biology.organism_classification ,Yeast ,Anti-Bacterial Agents ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,Vietnam ,Complementary and alternative medicine ,chemistry ,Enantiomer ,Water Microbiology ,Bacteria - Abstract
Analysis of an antimicrobial extract prepared from culture broth of the marine-derived actinomycete Nocardiopsis sp. (strain G057) led to the isolation of twelve compounds, 1–12. Compound 1 (2-[(2 R-hydroxypropanoyl)amino]benzamide) was found to be a new enantiomeric isomer while compounds 2 (3-acetyl-4-hydroxycinnoline) and 3 (3,3′-bis-indole) were isolated from a natural source for the first time. The structures of 1 – 12 were determined by analyses of MS and 2D NMR data. All compounds were evaluated for their antimicrobial activity against a panel of clinically significant microorganisms. Compound 1 selectively inhibited Escherichia coli (MIC: 16 μg/mL). Compounds 2 and 3 exhibited antimicrobial activity against several strains of both Gram-positive and Gram-negative bacteria, and the yeast Candida albicans. Cytotoxic evaluation of compounds 1 – 3 against four cancer cell lines (KB, LU-1, HepG-2 and MCF-7) indicated that compound 3 produced a weak inhibition against KB and LU cell lines. Two remaining compounds, 1 and 2 were not cytotoxic, even at the concentration of 128 μg/mL.
- Published
- 2016
- Full Text
- View/download PDF